Some recent reports have shown that ACKR3 is highly expressed in lung tissue and that the ACKR3 agonist TC14012 can decrease collagen I deposition and can protect the alveolar epithelial structure and function in a mouse model of bleomycin-induced lung fibrosis [44,45]. This evidence concerns the gene ACKR3 and pulmonary fibrosis.